Navigation Links
Researchers reveal secret of key protein in brain and heart function
Post Your Comments:
Breaking Biology News(10 mins):The Academy of Natural Sciences and Temple Press revive rare natural history work in new book 2Munich lab demonstrates diesel truck engine with barely measurable emissions 2Munich lab demonstrates diesel truck engine with barely measurable emissions 3Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4PET scans may improve accuracy of dementia diagnosis 48909 1PET scans may improve accuracy of dementia diagnosis 48909 2American Dental Association The Forsyth Institute Collaborate to Pilot Evidence Based Dentistry Training Course 48905 1American Dental Association The Forsyth Institute Collaborate to Pilot Evidence Based Dentistry Training Course 48905 2American Dental Association The Forsyth Institute Collaborate to Pilot Evidence Based Dentistry Training Course 48905 3Ted Karkus and Karkus Slate of Directors Prevail in Federal Court Seated as Directors of The Quigley Corporation 3B Ted Karkus Elected Chairman of th 48901 1Ted Karkus and Karkus Slate of Directors Prevail in Federal Court Seated as Directors of The Quigley Corporation 3B Ted Karkus Elected Chairman of th 48901 2Ted Karkus and Karkus Slate of Directors Prevail in Federal Court Seated as Directors of The Quigley Corporation 3B Ted Karkus Elected Chairman of th 48901 3Ted Karkus and Karkus Slate of Directors Prevail in Federal Court Seated as Directors of The Quigley Corporation 3B Ted Karkus Elected Chairman of th 48901 4
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3